Local injection of a glutamate uptake inhibitor into the ventral tegmental area produces sensitization to the behavioural effects of d-amphetamine

Autor: Paul G. Overton, David Clark, J. Aked, Véronique Coizet
Přispěvatelé: Department of Psychology [Sheffield], University of Sheffield [Sheffield], Department of Psychology, Swansea University, Savasta, Marc
Rok vydání: 2005
Předmět:
Male
Dextroamphetamine
Pyrrolidines
MESH: Rats
Microinjections
MESH: Piperazines
Glutamic Acid
Pharmacology
Motor Activity
MESH: Microinjections
Piperazines
MESH: Dextroamphetamine
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
MESH: Dicarboxylic Acids
medicine
Animals
MESH: Animals
Dicarboxylic Acids
Amphetamine
Neurotransmitter
Sensitization
030304 developmental biology
0303 health sciences
MESH: Pyrrolidines
Chemistry
General Neuroscience
Ventral Tegmental Area
Glutamate receptor
Rats
Inbred Strains

Glutamic acid
MESH: Excitatory Amino Acid Antagonists
MESH: Glutamic Acid
MESH: Rats
Inbred Strains

MESH: Male
MESH: Motor Activity
Rats
Ventral tegmental area
medicine.anatomical_structure
Anesthesia
MESH: Ventral Tegmental Area
NMDA receptor
Excitatory Amino Acid Antagonists
030217 neurology & neurosurgery
medicine.drug
Zdroj: Neuroscience
Neuroscience, Elsevier-International Brain Research Organization, 2005, 134 (2), pp.361-7. ⟨10.1016/j.neuroscience.2005.04.044⟩
ISSN: 0306-4522
1873-7544
DOI: 10.1016/j.neuroscience.2005.04.044⟩
Popis: International audience; Circumstantial evidence suggests that sensitization to the behavioral effects of d-amphetamine is mediated by increased glutamate levels in the ventral tegmental area. To test this directly, the present study examined whether increasing glutamate levels in the ventral tegmental area with a glutamate uptake inhibitor is sufficient, in the absence of d-amphetamine administration, to elicit sensitization to a subsequent d-amphetamine challenge. Rats were treated bilaterally once a day for 2 days with either intra-ventral tegmental area L-trans-pyrollidine-2,4-dicarboxylic acid (50 nmol), saline, L-trans-pyrollidine-2,4-dicarboxylic acid coadministered with the competitive N-methyl-d-aspartate antagonist (+/-)-3-(2-carboxy-piperazin-4-yl)-propyl-1-phosphonic acid; CPP, 0.5 nmol), or CPP alone (0.5 nmol; all 1.0 microl/side). Following a 2 day withdrawal period, all rats were administered systemic d-amphetamine (1 mg/kg, i.p.). Repeated intra-ventral tegmental area injection of L-trans-pyrollidine-2,4-dicarboxylic acid sensitized animals to the behavioral effects of a systemic d-amphetamine challenge, an action which was blocked by co-administration of CPP. The results directly implicate ventral tegmental area glutamate in the process of sensitization to d-amphetamine. Furthermore, they demonstrate that inhibition of glutamate uptake produces the neuroadaptations necessary to induce sensitization, adding support to the contention that d-amphetamine sensitizes by modulating glutamate uptake.
Databáze: OpenAIRE